Fox Run Management L.L.C. Buys New Shares in Stevanato Group S.p.A. (NYSE:STVN)

Fox Run Management L.L.C. purchased a new stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,544 shares of the company's stock, valued at approximately $317,000.

A number of other institutional investors have also recently made changes to their positions in STVN. Conestoga Capital Advisors LLC boosted its stake in Stevanato Group by 5.3% during the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock worth $176,128,000 after buying an additional 407,086 shares during the period. TimesSquare Capital Management LLC lifted its holdings in shares of Stevanato Group by 114.6% in the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock worth $71,657,000 after acquiring an additional 1,756,100 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Stevanato Group by 4.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company's stock worth $53,872,000 after purchasing an additional 115,050 shares during the period. Bamco Inc. NY grew its holdings in Stevanato Group by 1.3% during the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company's stock valued at $33,704,000 after purchasing an additional 21,469 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its position in Stevanato Group by 56.3% in the 4th quarter. Teacher Retirement System of Texas now owns 1,250,000 shares of the company's stock worth $27,238,000 after purchasing an additional 450,000 shares during the period.

Stevanato Group Stock Up 0.4 %

NYSE STVN traded up €0.08 ($0.09) during trading on Monday, reaching €20.37 ($22.14). 209,500 shares of the company's stock traded hands, compared to its average volume of 345,345. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.00) and a 12-month high of €32.98 ($35.85). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a market cap of $6.17 billion, a price-to-earnings ratio of 43.34, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60. The company's 50 day simple moving average is €20.84 and its two-hundred day simple moving average is €20.60.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of €0.20 ($0.22). The company had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. UBS Group cut their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. Morgan Stanley reiterated an "equal weight" rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Wolfe Research assumed coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an "outperform" rating and a $28.00 price target on the stock. Finally, Bank of America lifted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Stevanato Group presently has a consensus rating of "Moderate Buy" and an average price target of €25.70 ($27.93).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.